Funds · 13F holdings

CRCM LP

13F holdings for Q2 2026 · SAN FRANCISCO, CA · filed August 18, 2026

CRCM LP reported $304M in 13F securities across 14 holdings for Q2 2026, in a Form 13F filed August 18, 2026. The largest positions were iShares Gold TR (65.2%), IBIT (6.6%), RNA (5.7%). Reported value rose 115.3% from the quarter before. It opened 7 new positions, added to 6, trimmed 0 and sold out of 1.

13F value Q2 2026
$304M
Holdings
14
Change vs prior quarter
+115.3%
Rank by 13F value
#5,230

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Top holdings

StockValueWeightSharesChange in sharesMove
iShares Gold TR$198M65.2%2,627,642+110.2%Added
IBIT iShares Bitcoin Trust ETF$20.2M6.6%607,110NewNew
RNA Atrium Therapeutics Inc.$17.3M5.7%1,283,078NewNew
AIFC AI Financial Corporation$14.9M4.9%25,403,060+101.4%Added
PLBY Playboy Inc.$14.0M4.6%11,515,614+165.0%Added
BTGO BitGo Holdings Inc.$13.6M4.5%2,624,342NewNew
iShares TR$9.5M3.1%94,482NewNew
VZLA Vizsla Silver Corp.$5.6M1.8%1,696,432NewNew
BNR Burning Rock Biotech Limited$3.5M1.2%423,994+50.3%Added
Procap Acquisition Corp$3.3M1.1%321,312+110.9%Added
Perceptive Capital Solutions$2.1M0.7%194,530+67.3%Added
TRAX First Tracks Biotherapeutics Inc.$1.4M0.5%70,680NewNew
Usbc Inc.$174K0.1%555,3250%Unchanged
Procap Acquisition Corp$33K0.0%102,735NewNew

Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $304M in share positions; options and bonds count in the 13F value but not here.

Biggest buys in Q2 2026

  1. iShares Gold TR Added+$104M
  2. IBIT iShares Bitcoin Trust ETF New+$20.2M
  3. RNA Atrium Therapeutics Inc. New+$17.3M
  4. BTGO BitGo Holdings Inc. New+$13.6M
  5. iShares TR New+$9.5M
  6. PLBY Playboy Inc. Added+$8.7M
  7. AIFC AI Financial Corporation Added+$7.5M
  8. VZLA Vizsla Silver Corp. New+$5.6M
  9. Procap Acquisition Corp Added+$1.7M
  10. TRAX First Tracks Biotherapeutics Inc. New+$1.4M

Biggest sells in Q2 2026

  1. STAA STAAR Surgical Company Sold out-$1.9M

The change in shares since Q1 2026, adjusted for stock splits and priced at the Q2 2026 value per share. 7 new, 6 added, 0 trimmed, 1 sold out.

Sector mix

13F value by quarter

Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Q2 '26
Reported 13F value: Q1 2024 $133M, Q2 2024 $138M, Q3 2024 $154M, Q4 2024 $246M, Q1 2025 $245M, Q2 2025 $337M, Q3 2025 $346M, Q4 2025 $296M, Q1 2026 $141M, Q2 2026 $304M.

Schedule 13D and 13G filings by CRCM LP

Stakes above 5% of a company, filed within days rather than once a quarter.

Questions about CRCM LP

What does CRCM LP own?
In its Form 13F for Q2 2026, CRCM LP reported 14 holdings worth $304M. The five largest were iShares Gold TR, IBIT, RNA, AIFC, PLBY.
What did CRCM LP buy and sell in Q2 2026?
CRCM LP opened 7 new positions, added to 6, trimmed 0 and sold out of 1 compared with the quarter before.
When did CRCM LP file its latest 13F?
Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 18, 2026.

From Form 13F filed by CRCM LP (SEC CIK 0001483234) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds